The molecular mimicry mechanism between cow's milk proteins and human insulin and GAD-65 provides a potential environmental trigger for T1DM development in genetically predisposed individuals. The present study was performed to investigate the possibility of cow’s milk proteins BSA and BLG share homology with GAD-65, Human insulin and ZnT8 to cause the T1DM.
One of the environmental factors that have been implicated in the development of T1DM is cow's milk. Cow's milk contains several proteins that may trigger an autoimmune response in susceptible individuals. Two of these proteins are BLG and BSA (7).
Several studies have investigated the role of molecular mimicry between cow's milk proteins and GAD-65/human insulin/ZnT in the development of T1DM. Some studies have reported that cow's milk consumption during infancy is associated with an increased risk of developing T1DM later in life, while others have failed to find a significant association. One of the limitations of these studies is the difficulty in establishing an accurate measure of cow's milk consumption. Cow's milk is often used as an ingredient in many processed foods, making it difficult to accurately assess the amount of cow's milk consumed by an individual.
One of the earliest studies on molecular mimicry in DM1 was conducted by Elliott et al. (8). The authors used monoclonal antibodies to examine the cross-reactivity between GAD65 and several proteins, including BSA and BLG, the two most abundant proteins in cow milk. The study found that some of the monoclonal antibodies created against BSA and BLG recognized GAD-65, indicating a structural similarity between the two proteins. However, the authors did not investigate the clinical implications of this observation.
Another study provided evidence for the role of molecular mimicry in the development of DM1. The authors demonstrated that feeding cow milk formula to infants who carried the HLA-DQB1*0201 allele, a genetic risk factor for DM1, increased the risk of developing islet autoantibodies. They also showed that the autoantibodies recognized an epitope in BSA that shared structural similarity with GAD-65. The authors concluded that cow milk proteins could induce the production of autoantibodies against GAD-65 through molecular mimicry, which could contribute to the development of DM1 (9).
BSA has been shown to share structural similarities with GAD-65 (10). The molecular mimicry between cow's milk proteins and GAD-65 has been suggested as another potential trigger of T1DM. GAD-65 is an enzyme in pancreatic beta cells that catalyzes the conversion of glutamate to gamma-aminobutyric acid. GAD-65 is a major autoantigen in T1DM, and autoantibodies to GAD-65 are detected in 60–70% of newly diagnosed with T1DM individuals, suggesting that the destruction of beta-cells may be mediated by the immune response against GAD-65 (11).
Despite their different functions and structures, BSA and GAD-65 share a certain degree of amino acid similarity. Several studies have reported sequence alignments and comparisons between BSA and GAD-65 using bioinformatics tools. Study using multiple sequence alignment to compare the amino acid sequences of BSA and GAD-65, found that the two proteins presented 29% sequence identity and 48% sequence similarity, with most of the similar residues located in the flexible loops and turns of the proteins (12). Our study, using pairwise structure alignment analysis, compared the amino acid sequences of BSA and GAD-65. The evaluation between these two proteins showed a lower percentage than the studies presented in the literature, being 19.64% sequence identity and 20.54% sequence similarity, with most of the similar residues located in the flexible loops and bends of the proteins. In addition, we used homology modeling to generate a 3D structure of BSA and compared it to the crystal structure of GAD-65. Our results showed that BSA shares an overall fold similar to that of GAD-65, which has not been described in previous studies.
We found no studies in the literature evaluating the similarity between GAD-65 and BLG. In our study, we compared the amino acid sequences of BLG and GAD-65, which showed 18.25% sequence identity and 19.15% sequence similarity between these two proteins.
Insulin and BLG, despite their distinct functions, these two molecules share a resemblance in their amino acid sequences. Several studies have suggested that the amino acid sequence of BLG contains regions that resemble the amino acid sequence of human insulin, thereby leading to molecular mimicry. Molecular mimicry occurs when a foreign antigen (in this case, BLG) shares structural similarities with a self-antigen (in this case, human insulin), leading to cross-reactivity of T cells and autoimmunity (13).
Several scientific papers have evaluated molecular mimicry between insulin and cow's milk proteins in in silico studies on the triggering of T1DM. These studies aimed to investigate the structural and immunological similarities between the two proteins, and their potential role in the development of autoimmune reactions leading to diabetes. Previous studies have shown that antibody cross-reactivity between human insulin and BLG is possible, indicating that molecular mimicry may be a contributing factor (14), however we found no in silico studies in the literature comparing the similarity between BLG and human insulin. Our study using Pairwise Structure Alignment analysis compared the amino acid sequences of BGL and human insulin, the evaluation between these two proteins showed 26.43% sequence identity and 27.27% sequence similarity, and structurally showed a required minimum distributions indicative of good similarity.
Reviewing the medical literature, we found no studies in which the similarity between human insulin and BSA was assessed. In our study, we compared the amino acid sequences of human insulin and BSA, which showed a sequence identity of 18.25% and a sequence similarity of 19.15% between these two proteins.
Analysis focused on discovering beta-cell-specific proteins associated with the regulatory pathway of secretion recently identified ZnT8 as a novel autoantigen (15). ZnT8 is found in the membrane of insulin-containing secretory granules and is responsible for transporting zinc ions from the cytosol into the vesicles (16). ZnT8 has emerged as a potential target for humoral autoimmunity, making it highly relevant for the early detection of T1DM. The presence of ZnT8-specific CD8 + T cells can be observed in the majority of T1DM patients, and these cells play a crucial role in the development of T1DM. As a target for immunotherapy, ZnT8 offers the potential to ameliorate beta cell dysfunction in T1DM, presenting new avenues for the treatment of this condition (17).
It has been reported that anti-ZnT8 antibodies which target homologous membrane extension sequences exhibit cross-reactivity and have the ability to elicit robust immune responses, thus raising the possibility of a molecular mimicry mechanism that triggers T1DM (18). Literature suggests that infection with Mycobacterium avium subspecies paratuberculosis is linked to T1DM by production of anti-ZnT8 antibodies via molecular homology (19). However, there are no studies available which are related to molecular mimicry between cow’s milk proteins and ZnT8. Our study compared the amino acid sequences of BSA and ZnT8. The evaluation between these two proteins showed 18.25% sequence identity and 21.70% sequence similarity. When comparing the amino acid sequences of ZnT8 and BSL, we found a sequence identity of 26.43% and a sequence similarity of 27.27% between these two proteins.
In view of the above, we must take into account that in silico studies to determine the triggering of T2DM by molecular mimicry between human pancreatic beta-cell antigens and cow's milk proteins show several limitations must be acknowledged. Firstly, the molecular mimicry mechanism is not the only environmental trigger for T1DM development. Other factors such as viral infections, gut microbiota, and dietary factors may also contribute to T1DM pathogenesis (20). Secondly, the evidence for the molecular mimicry between cow's milk proteins and human insulin, GAD-65 and ZnT8 are mainly based on in vitro studies, and the clinical significance of these findings is still unclear.